which glp 1 has the fewest side effects Why Constipation Matters While on GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated effect of GLP-1 and GIP-1 agonists like semaglutide (Wegovy®) or tirzepatide (Zepbound®). Left untreated, it can lead Genetic predictors of GLP1 receptor
Description
The medication does not cause the rapid, unsustainable weight loss associated with older stimulant-based diet drugs
Nauck et al, 2021)
If you are travelling within similar time zones, maintaining your regular injection day and time is straightforward
Patients with pre-existing gastroparesis, gastric ulcers, or severe reflux disease should discuss GLP-1 candidacy carefully with their physician
The SLIMMER Phase 3 trial positioned ecnoglutide as a competitive GLP-1 agonist, with 15.4% weight loss at 48 weeks that approaches semaglutide's established efficacy, though the comparison is limited by differences in trial populations and duration
